Skip to main content
SpringerLink
Log in

Neuropharmacology of Rhodiola rosea L.

  • Chapter
  • First Online:
Pharmacotherapeutic Potential of Natural Products in Neurological Disorders

Abstract

R. rosea (Crassulaceae) is commonly known as roseroot (Sagalov 1983). The plant is native to dry, high-altitude regions of the northern hemisphere. R. rosea is better described as adaptogen in herbal medicine. R. rosea is a herbaceous perennial plant with a thick rhizome. R. rosea is one of the best-known herbal remedies for fatigue (Tharakan and Manyam 2006).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Amsterdam JD, Panossian AG. Rhodiola rosea L. as a putative botanical antidepressant. Phytomedicine. 2016;23:770–83.

    Article  PubMed  Google Scholar 

  • Andreeva L, BoÄ­kova AA, Nikiforova DV. Evaluating adaptogenic properties of Rhodiola rosea extract in human mononuclear cell culture and rat tissues. Eksp Klin Farmakol. 2013;76:23–7.

    PubMed  CAS  Google Scholar 

  • Atochin DN, Chernysheva GA, Smolyakova VI, Osipenko AN, Logvinov SV, Zhdankina AA, Sysolyatin SV, Kryukov YA, Anfinogenova Y, Plotnikova TM, Plotnikov MB. Neuroprotective effects of p-tyrosol after the global cerebral ischemia in rats. Phytomedicine. 2016;23:784–92.

    Article  PubMed  CAS  Google Scholar 

  • Bystritsky A, Kerwin L, Feusner JD. A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD). J Altern Complement Med. 2008;14:175–80.

    Article  PubMed  Google Scholar 

  • Cayer C, Ahmed F, Filion V, Saleem A, Cuerrier A, Allard M, Rochefort G, Merali Z, Arnason JT. Characterization of the anxiolytic activity of Nunavik Rhodiola rosea. Planta Med. 2013;79:1385–91.

    Article  PubMed  CAS  Google Scholar 

  • Chen QG, Zeng YS, Tang JY, Qin YJ, Chen SJ, Zhong ZQ. Effects of Rhodiola rosea on body weight and intake of sucrose and water in depressive rats induced by chronic mild stress. Zhong Xi Yi Jie He Xue Bao. 2008;6:952–5.

    Article  PubMed  CAS  Google Scholar 

  • Chen QG, Zeng YS, Qu ZQ, Tang JY, Qin YJ, Chung P, Wong R, Hägg U. The effects of Rhodiola rosea extract on 5-HT level, cell proliferation and quantity of neurons at cerebral hippocampus of depressive rats. Phytomedicine. 2009;16:830–8.

    Article  PubMed  CAS  Google Scholar 

  • Darbinyan V, Aslanyan G, Amroyan E, Gabrielyan E, Malmström C, Panossian A. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nord J Psychiatry. 2007;61:343–8.

    Article  PubMed  CAS  Google Scholar 

  • Lai W, Zheng Z, Zhang X, Wei Y, Chu K, Brown J, Hong G, Chen L. Salidroside-mediated neuroprotection is associated with induction of early growth response genes (Egrs) across a wide therapeutic window. Neurotox Res. 2015;28:108–21.

    Article  PubMed  CAS  Google Scholar 

  • Mao JJ, Xie SX, Zee J, Soeller I, Li QS, Rockwell K, Amsterdam JD. Rhodiola rosea versus sertraline for major depressive disorder: a randomized placebo-controlled trial. Phytomedicine. 2015;22:394–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Mattioli L, Perfumi M. Rhodiola rosea L. extract reduces stress- and CRF-induced anorexia in rats. J Psychopharmacol. 2007;21:742–50.

    Article  PubMed  Google Scholar 

  • Mattioli L, Funari C, Perfumi M. Effects of Rhodiola rosea L. extract on behavioural and physiological alterations induced by chronic mild stress in female rats. J Psychopharmacol. 2009;23:130–42.

    Article  PubMed  CAS  Google Scholar 

  • Olsson EM, von Schéele B, Panossian AG. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med. 2009;75:105–12.

    Article  PubMed  CAS  Google Scholar 

  • Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 2010;17:481–93.

    Article  PubMed  CAS  Google Scholar 

  • Perfumi M, Mattioli L. Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytother Res. 2007;21:37–43.

    Article  PubMed  CAS  Google Scholar 

  • Petkov VD, Yonkov D, Mosharoff A, Kambourova T, Alova L, Petkov VV, et al. Effects of alcohol aqueous extract from Rhodiola rosea L. roots on learning and memory. Acta Physiol Pharmacol Bulg. 1986;12:3–16.

    PubMed  CAS  Google Scholar 

  • Qin YJ, Zeng YS, Zhou CC, Li Y, Zhong ZQ. Effects of Rhodiola rosea on level of 5-hydroxytryptamine, cell proliferation and differentiation, and number of neuron in cerebral hippocampus of rats with depression induced by chronic mild stress. Zhongguo Zhong Yao Za Zhi. 2008;33:2842–6.

    PubMed  Google Scholar 

  • Ross SM. Rhodiola rosea (SHR-5), Part 2: a standardized extract of Rhodiola rosea is shown to be effective in the treatment of mild to moderate depression. Holist Nurs Pract. 2014a;28:217–21.

    Article  PubMed  Google Scholar 

  • Ross SM. Rhodiola rosea (SHR-5), Part I: a proprietary root extract of Rhodiola rosea is found to be effective in the treatment of stress-related fatigue. Holist Nurs Pract. 2014b;28:149–54.

    Article  PubMed  Google Scholar 

  • Sagalov GM. Rhodiola rosea. Feldsher Akush. 1983;48:55–6.

    PubMed  CAS  Google Scholar 

  • Sheng QS, Wang ZJ, Zhang J, Zhang YG. Salidroside promotes peripheral nerve regeneration following crush injury to the sciatic nerve in rats. Neuroreport. 2013;24:217–23.

    Article  PubMed  Google Scholar 

  • Shi TY, Feng SF, Xing JH, Wu YM, Li XQ, Zhang N, Tian Z, Liu SB, Zhao MG. Neuroprotective effects of Salidroside and its analogue tyrosol galactoside against focal cerebral ischemia in vivo and H2O2-induced neurotoxicity in vitro. Neurotox Res. 2012;21:358–67.

    Article  PubMed  CAS  Google Scholar 

  • Sun L, Isaak CK, Zhou Y, Petkau JC, O K LY, Siow YL. Salidroside and tyrosol from Rhodiola protect H9c2 cells from ischemia/reperfusion-induced apoptosis. Life Sci. 2012;91:151–8.

    Article  PubMed  CAS  Google Scholar 

  • Tharakan B, Manyam BV. Botanical therapies in chronic fatigue. Phytothear Res. 2006;20:91–5.

    Article  Google Scholar 

  • Thieme H. On the identity of glucoside rhodioloside and salidroside. Pharmazie. 1969;24:118–9.

    PubMed  CAS  Google Scholar 

  • Tolonen A, Pakonen M, Hohtola A, Jalonen J. Phenylpropanoid glycosides from Rhodiola rosea. Chem Pharm Bull (Tokyo). 2003;51:467–70.

    Article  CAS  Google Scholar 

  • van Diermen D, Marston A, Bravo J, Reist M, Carrupt PA, Hostettmann K. Monoamine oxidase inhibition by Rhodiola rosea L. roots. J Ethnopharmacol. 2009;122:397–401.

    Article  PubMed  Google Scholar 

  • Vasileva LV, Getova DP, Doncheva ND, Marchev AS, Georgiev MI. Beneficial effect of commercial Rhodiola extract in rats with scopolamine-induced memory impairment on active avoidance. J Ethnopharmacol. 2016;193:586–91.

    Article  PubMed  CAS  Google Scholar 

  • Yan ZQ, Chen J, Xing GX, Huang JG, Hou XH, Zhang Y. Salidroside prevents cognitive impairment induced by chronic cerebral hypoperfusion in rats. J Int Med Res. 2015;43:402–11.

    Article  PubMed  CAS  Google Scholar 

  • Yang SJ, Yu HY, Kang DY, Ma ZQ, Qu R, Fu Q, Ma SP. Antidepressant-like effects of salidroside on olfactory bulbectomy-induced pro-inflammatory cytokine production and hyperactivity of HPA axis in rats. Pharmacol Biochem Behav. 2014;124:451–7.

    Article  PubMed  CAS  Google Scholar 

  • Zhang L, Yu H, Sun Y, Lin X, Chen B, Tan C, Cao G, Wang Z. Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Eur J Pharmacol. 2007;564:18–25.

    Article  PubMed  CAS  Google Scholar 

  • Zhang L, Yu H, Zhao X, Lin X, Tan C, Cao G, Wang Z. Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells. Neurochem Int. 2010;57:547–55.

    Article  CAS  PubMed  Google Scholar 

  • Zhang X, Du Q, Liu C, Yang Y, Wang J, Duan S, Duan J. Rhodioloside ameliorates depressive behavior via up-regulation of monoaminergic system activity and anti-inflammatory effect in olfactory bulbectomized rats. Int Immunopharmacol. 2016;36:300–4.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Herbal Consultant, Mohali, Punjab, India

    Amritpal Singh Saroya

  2. Department of Pharmacology, Sri Guru Ram Das Institute of Medical Science, Amritsar, Punjab, India

    Jaswinder Singh

Authors
  1. Amritpal Singh Saroya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaswinder Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Saroya, A.S., Singh, J. (2018). Neuropharmacology of Rhodiola rosea L.. In: Pharmacotherapeutic Potential of Natural Products in Neurological Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-13-0289-3_14

Download citation

Publish with us

Policies and ethics

Search

Navigation